TL;DR: PipeBio is a Y Combinator Winter 2021 startup a SaaS bioinformatics platform to develop antibody drugs., currently acquired with a team of 10.
PipeBio is a SaaS bioinformatics platform to develop antibody drugs.
Last verified:
Pipe|bio is the bioinformatics cloud for antibody / peptide screening & drug development. We enable scientists to analyze and manage massive amounts of DNA sequencing data themselves without the need for bioinformaticians or programmers. The software is highly visual and enables you to overlay and filter information from different sources across your organization; be it assay data, sequence data or other process metadata. Insights from past results can be used to guide new experiments and they get better as you upload more and more data. Team leads get oversight and these capabilities combined empower organizations to find better drugs, faster. We believe that science moves faster when scientists can curate and analyse their own data.
Built by LemStudio
Yes. PipeBio was funded by Y Combinator in the Winter 2021 batch. PipeBio is a SaaS bioinformatics platform to develop antibody drugs.
Pipe|bio is the bioinformatics cloud for antibody / peptide screening & drug development. We enable scientists to analyze and manage massive amounts of DNA sequencing data themselves without the need for bioinformaticians or programmers. The software is highly visual and enables you to overlay and filter information f…
PipeBio was part of Y Combinator's Winter 2021 batch.
PipeBio has a team of 10 people according to Y Combinator's directory.
PipeBio is currently listed as Acquired with a team of 10 in Y Combinator's directory.
Loading interactive view…